Northeast Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 25.64% vs -1.77% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -71.13% vs 54.35% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,006.20",
          "val2": "1,596.80",
          "chgp": "25.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "33.60",
          "val2": "175.60",
          "chgp": "-80.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "10.60",
          "val2": "13.40",
          "chgp": "-20.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.40",
          "val2": "56.80",
          "chgp": "-71.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.80%",
          "val2": "29.40%",
          "chgp": "-1.26%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -5.69% vs -8.52% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -48.55% vs 12.58% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,041.10",
          "val2": "7,466.00",
          "chgp": "-5.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "802.80",
          "val2": "1,060.30",
          "chgp": "-24.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "82.50",
          "val2": "112.50",
          "chgp": "-26.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-37.40",
          "val2": "-37.20",
          "chgp": "-0.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "217.80",
          "val2": "423.30",
          "chgp": "-48.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.90%",
          "val2": "65.30%",
          "chgp": "-2.94%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

2,006.20

1,596.80

25.64%

Operating Profit (PBDIT) excl Other Income

33.60

175.60

-80.87%

Interest

10.60

13.40

-20.90%

Exceptional Items

-3.00

-0.00

Consolidate Net Profit

16.40

56.80

-71.13%

Operating Profit Margin (Excl OI)

16.80%

29.40%

-1.26%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 25.64% vs -1.77% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -71.13% vs 54.35% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

7,041.10

7,466.00

-5.69%

Operating Profit (PBDIT) excl Other Income

802.80

1,060.30

-24.29%

Interest

82.50

112.50

-26.67%

Exceptional Items

-37.40

-37.20

-0.54%

Consolidate Net Profit

217.80

423.30

-48.55%

Operating Profit Margin (Excl OI)

35.90%

65.30%

-2.94%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -5.69% vs -8.52% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -48.55% vs 12.58% in Dec 2024

All Annual Results